Cross‐country generalizability of quality‐of‐life scores in atopic dermatitis

Rencz, Fanni

doi:10.1111/bjd.18601

Cited by 2 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…AD can significantly impact patients’ ability to work, indicating that indirect costs associated with AD may be substantial [ 16 ]. A comprehensive European study found that 57% of patients with AD missed at least one day of work in the previous year due to their skin condition [ 17 ].…”

Section: Introductionmentioning

confidence: 99%

Societal costs and health related quality of life in adult atopic dermatitis

Beretzky

Koszorú

Rencz

et al. 2023

BMC Health Serv Res

View full text Add to dashboard Cite

Background Cost-of-illness studies are widely used for healthcare decision-making in chronic conditions. Our aim was to assess the cost-of-illness of adult atopic dermatitis (AD) from the societal perspective in Hungary. Methods We conducted a multicentre, cross-sectional questionnaire survey between February 2018 and January 2021. Data was collected from consecutive AD patients aged ≥ 18 years and their physicians at dermatology departments in Hungary. We calculated direct and indirect costs, including costs for treatments, outpatient visits, hospital admissions, informal care, travel costs and productivity loss. To assess indirect costs, the Work Productivity and Activity Impairment (WPAI) questionnaire was used to collect data, and costs were estimated with the human capital approach. Generalized linear model was used to analyse predictors of total, direct and indirect costs. Results Altogether 218 patients completed the survey (57.8% female) with an average age of 31.3 (SD = 11.7). Patients’ average Dermatology Life Quality Index (DLQI) score was 13.5 (SD = 8.5). According to Eczema Area and Severity Index (EASI) score, 2.3% (n = 5), 21.2% (n = 46), 54.4% (n = 118) and 22.1% (n = 48) had clear, mild, moderate, and severe AD, respectively. We found that the average total, direct medical, direct non-medical and indirect annual costs per patients were €4,331, €1,136, €747, and €2450, respectively, with absenteeism and presenteeism being the main cost drivers, accounting for 24% and 29% of the total cost of AD. A one-year longer disease duration led to, on average, 1.6%, and 4.2% increase in total and direct non-medical costs, respectively. Patients with worse health-related quality of life (higher DLQI score) had significantly higher total, direct medical, direct non-medical costs, and indirect costs. Conclusions Our results indicate a substantial economic burden of AD from a societal perspective, mainly driven by productivity losses.

show abstract

Section: Introductionmentioning

confidence: 99%

Societal costs and health related quality of life in adult atopic dermatitis

Beretzky

Koszorú

Rencz

et al. 2023

BMC Health Serv Res

View full text Add to dashboard Cite

show abstract

Cost-of-illness of adult atopic dermatitis from a societal perspective in Hungary

Beretzky

Koszorú

Rencz

et al. 2023

Preprint

View full text Add to dashboard Cite

Introduction: Cost-of-illness studies are widely used for healthcare decision-making in chronic conditions. Our aim was to assess the cost-of-illness of adult atopic dermatitis (AD) from the societal perspective in Hungary. Areas covered: We conducted a multicentre, cross-sectional questionnaire survey. Consecutive AD patients aged ≥18 years were recruited at dermatology departments in Hungary. We calculated direct and indirect costs, including costs for treatments, outpatient visits, hospital admissions, informal care, travel costs and productivity loss. Generalized linear model was used to analyse predictors of total, direct and indirect costs. Expert Commentary: Altogether 218 patients completed the survey (57.8% female) with an average age of 31.3 (SD=11.7). Patients’ average Dermatology Life Quality Index (DLQI) score was 13.5 (SD=8.5). According to Eczema Area and Severity Index (EASI) score, 2.3% (n=5), 21.2% (n=46), 54.4% (n=118) and 22.1% (n=48) had clear, mild, moderate, and severe AD, respectively. We found that the average total, direct medical, direct non-medical and indirect annual costs per patients were €4,331, €1,136, €747, and €2450, respectively, with absenteeism and presenteeism being the main cost drivers, accounting for 24% and 29% of the total cost of AD. A one-year longer disease duration led to, on average, 1.6%, and 4.2% increase in total and direct non-medical costs, respectively. Patients with worse health-related quality of life (higher DLQI score) had significantly higher total, direct medical, direct non-medical costs, and indirect costs. Our results indicate a substantial economic burden of AD from a societal perspective, mainly driven by productivity losses.

show abstract

Cross‐country generalizability of quality‐of‐life scores in atopic dermatitis

Abstract: Linked Article: Andersen et al. Br J Dermatol 2020; 182:1176–1183.

Cited by 2 publications

References 9 publications

Societal costs and health related quality of life in adult atopic dermatitis

Societal costs and health related quality of life in adult atopic dermatitis

Cost-of-illness of adult atopic dermatitis from a societal perspective in Hungary

Contact Info

Product

Resources

About